Organon & Co.

Organon & Co. ( Organon, the Company, we, our, or us ) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. With a portfolio of over 70 products across women’s health and general medicines, which includes biosimilars, Organon focuses on addressing health needs that uniquely, disproportionately or differently affect women, while expanding access to essential treatments in over 140 countries and territories. We sell these products through various channels including drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers such as health maintenance organizations, pharmacy benefit managers and other institutions. We operate six manufacturing facilities, which are located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the United Kingdom ( UK ). Unless otherwise indicated, trademarks appearing in italics throughout this document are trademarks of, or are used under license by, the Organon group of companies. Our operations include the following product portfolios: Women’s Health : Our women’s health portfolio of products is sold by prescription primarily in two therapeutic areas: contraception, with key brands such as Nexplanon (etonogestrel implant) (sold as Implanon NXT in some countries outside the United States) and NuvaRing (etonogestrel / ethinyl estradiol vaginal ring); and fertility, with key brands such as Follistim AQ (follitropin beta injection) (marketed in most countries outside the United States as Puregon ).